LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $618,000 | -30.2% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $886,000 | +4.7% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $846,000 | -12.8% | 8,500 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $970,000 | -9.3% | 8,500 | 0.0% | 0.01% | -12.5% |
| Q1 2019 | $1,069,000 | +31.3% | 8,500 | +41.7% | 0.01% | +14.3% |
| Q4 2018 | $814,000 | -1.1% | 6,000 | +100.0% | 0.01% | +16.7% |
| Q3 2018 | $823,000 | +32.3% | 3,000 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $622,000 | -37.2% | 3,000 | -50.0% | 0.00% | -42.9% |
| Q1 2018 | $991,000 | +20.6% | 6,000 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $822,000 | +20.7% | 6,000 | +20.0% | 0.01% | +25.0% |
| Q3 2017 | $681,000 | +12.2% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $607,000 | +14.7% | 5,000 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $529,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |